DEVON LABS and SALUDA MEDICAL have signed an agreement for the distribution of Evoke™ in Spain. Evoke™ is the first and only closed-loop spinal cord stimulation (SCS) system to treat chronic pain, a condition that affects more than 540 million people globally. SCS treats the condition by stimulating the spinal cord and altering the transmission of pain signals to the brain. Saluda’s proprietary Evoke™ System is the only closed-loop SCS system designed to provide real-time customization of waveforms to each unique evoked compound action potential (ECAP) at the same rate as the stimulation frequency (>100 times per second) to deliver consistent therapy within a patient’s individual therapeutic window.
Saluda Medical is a global neuromodulation company based in Australia, leading the development and commercialization of data-driven, personalized therapies for patients with chronic pain. Saluda is pioneering the field of closed-loop SCS with the Evoke™ System, which is designed to provide consistent therapy within a patient’s preferred levels and avoid periods of over and under-stimulation.
DEVON LABS is a recently created Spanish Company made up of professionals with extensive experience in commercializing products for patients suffering from severe Pain. Following its innovative spirit, a collaboration agreement has been established with Saluda Medical for the commercialization of EVOKE™. With this agreement, Devon Labs goes one step further to offer the latest advances in the treatment of chronic Pain to both specialists and patients.